Highest-Volume Intravitreal Injection (Anti-VEGF) Surgeons in Minnesota (2026 update)
80 Minnesota providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in 2024. The top 10 by case volume are below — the full ranked list, CSV export and competitor-payment intel are available with a DocVol subscription ($199/mo, cancel anytime).
Database refreshed July 2026Live NPPES registryⓘ sources
| # | Surgeon | Location | Medicare cases (2024) |
|---|---|---|---|
| 1 | David Williams, MD | Baxter, MN | 3,233 |
| 2 | Dale Reynolds, M.D. PH.D. | Sartell, MN | 2,860 |
| 3 | David Parke, MD | Minneapolis, MN | 2,585 |
| 4 | Sundeep Dev, MD | Minneapolis, MN | 2,443 |
| 5 | John Davies, MD | Minneapolis, MN | 2,310 |
| 6 | Polly Quiram, MD | Minneapolis, MN | 2,207 |
| 7 | Geoffrey Emerson, MD | Minneapolis, MN | 2,107 |
| 8 | Robert Mittra, MD | Minneapolis, MN | 1,995 |
| 9 | Jacob Jones, M.D. | Minneapolis, MN | 1,529 |
| 10 | Michael Emerson, MD | Minneapolis, MN | 1,525 |
70 more Minnesota surgeons in the full list
Plus: who already pays them (Stryker? Medtronic? Arthrex?), CSV export for your CRM, and every other state and procedure.
Search the full databaseFrequently asked questions
- How many surgeons perform Intravitreal Injection (Anti-VEGF) in Minnesota?
- 80 Minnesota providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in CY2024. CMS suppresses providers with 10 or fewer Medicare patients, so the true count is somewhat higher.
- Where does this data come from?
- CMS Medicare Physician & Other Practitioners (fee-for-service Part B claims, CY2024, released May 2026) and CMS Open Payments. Both are official U.S. federal datasets.
- Does this include all of a surgeon's cases?
- No — it covers traditional Medicare only (no Medicare Advantage, commercial, or Medicaid claims). Absolute volumes undercount total practice, but the ranking of high- vs low-volume surgeons is a strong targeting signal.